Logo Precision Medicine in Chronic Inflammation
DE EN

The new PMI website is still being developed, so we are getting started with a provisional one.
 

News

19.08.2019
Intestinal bacteria in type 2 diabetes: being overweight is pivotal (pdf)
A Kiel-based research team has been able to show that changes in the composition of intestinal bacteria in those with type 2 diabetes is linked more to being overweight and taking supplements or medication, and less to diabetes itself.
14.08.2019
Plan B for Cholesterol Transport
Prof. Paul Saftig and his team prove the existence of a previously unknown alternative cholesterol transport mechanism inside cells
22.07.2019
Inflammatory Bowel Disease: Assessment of metabolism of intestinal bacteria helps predict treatment success
Members of the Cluster of Excellence "Precision Medicine in Chronic Inflammation" (PMI) have developed a new approach for personalized medicine in patients with inflammatory bowel diseases.
21.05.2019
Cluster member Michael Stolpe of the Kiel Institute for the World Economy will give invited presentation on "Using Evidence-based Medicine to Raise the Productivity of Healthcare in Aging Populations" at the T20 Summit on 26-27 May 2019 in Tokyo, a high-level conference of the research and policy advice network for the G20 countries “Think20”. The summit is hosted by the government of Japan and the Asian Development Bank Institute (ADBI) in preparation of the G20 Summit of world leaders at the end of June 2019 in Osaka. For more information, go to https://t20japan.org. Download Michael Stolpe's Policy Brief "Use Evidence-based Medicine to Raise the Productivity of Healthcare in Aging Populations" at https://t20japan.org/policy-brief-productivity-healthcare-aging-populations/